Protocol for mathematical prediction of patient response and survival to immune checkpoint inhibitor immunotherapy

被引:1
|
作者
Butner, Joseph D. [1 ]
Farhat, Maguy [2 ]
Cristini, Vittorio [1 ,3 ,4 ,5 ]
Chung, Caroline [2 ]
Wang, Zhihui [1 ,3 ,6 ,7 ]
机构
[1] Houston Methodist Res Inst, Math Med Program, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[3] Houston Methodist Res Inst, Neal Canc Ctr, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77230 USA
[5] Weill Cornell Med, Grad Sch Med Sci, Physiol Biophys & Syst Biol Program, New York, NY 10065 USA
[6] Weill Cornell Med, Dept Physiol & Biophys, New York, NY 10065 USA
[7] Texas A&M Univ, Dept Med Educ, Sch Med, Bryan, TX 77807 USA
来源
STAR PROTOCOLS | 2022年 / 3卷 / 04期
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
Biotechnology and bioengineering; Cancer; Health Sciences; Immunology; Systems biology;
D O I
10.1016/j.xpro.2022.101886
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
This protocol describes the application of a mechanistic mathematical model of immune checkpoint inhibitor (ICI) immunotherapy to patient tumor imaging data for predicting solid tumor response and patient survival under ICI intervention. We describe steps for data collection and processing, data pipelines, and approaches to increase precision. The protocol is highly predictive as early as the first restaging after treatment start and can be used with standard-of-care imaging measures. For complete details on the use and execution of this protocol, please refer to Butner et al. (2020)1 and Butner et al. (2021).2
引用
收藏
页数:17
相关论文
共 50 条
  • [21] A comprehensive analysis of genomic determinants of response to immune checkpoint inhibitor-based immunotherapy.
    Yang, Jing
    Liu, Qi
    Shyr, Yu
    CANCER RESEARCH, 2022, 82 (12)
  • [22] Challenges of the Immunotherapy: Perspectives and Limitations of the Immune Checkpoint Inhibitor Treatment
    Dobosz, Paula
    Stepien, Maria
    Golke, Anna
    Dzieciatkowski, Tomasz
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)
  • [23] Current Status of Immune Checkpoint Inhibitor Immunotherapy for Lung Cancer
    Xiong, Wei
    Zhao, Yunfeng
    Du, He
    Guo, Xuejun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [24] Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma
    Lee, Pei-Chang
    Chao, Yee
    Chen, Ming-Huang
    Lan, Keng-Hsin
    Lee, Chieh-Ju
    Lee, I-Cheng
    Chen, San-Chi
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    CANCERS, 2020, 12 (01)
  • [25] Modelling of Immune Checkpoint Network Explains Synergistic Effects of Combined Immune Checkpoint Inhibitor Therapy and the Impact of Cytokines in Patient Response
    Kondratova, Maria
    Barillot, Emmanuel
    Zinovyev, Andrei
    Calzone, Laurence
    CANCERS, 2020, 12 (12) : 1 - 19
  • [26] MATHEMATICAL MODELING OF AN IMMUNE CHECKPOINT INHIBITOR AND ITS SYNERGY WITH AN IMMUNOSTIMULANT
    Nikolopoulou, Elpiniki
    Eikenberry, Steffen E.
    Gevertz, Jana L.
    Kuang, Yang
    DISCRETE AND CONTINUOUS DYNAMICAL SYSTEMS-SERIES B, 2021, 26 (04): : 2133 - 2159
  • [27] PREDICTION OF IMMUNE CHECKPOINT INHIBITOR TREATMENT RESPONSE IN HEPATOCELLULAR CARCINOMA USING CT RADIOMICS
    Min, Ji Hye
    Chen, Pin-Jung
    Qureshi, Touseef
    Xie, Yibin
    Azab, Linda
    Wang, Lixia
    Kim, Hyunseok
    Li, Debiao
    Yang, Ju Dong
    HEPATOLOGY, 2024, 80 : S1500 - S1501
  • [28] The Role of Biomarkers for the Prediction of Response to Checkpoint Immunotherapy and the Rationale for the Use of Checkpoint Immunotherapy in Cervical Cancer
    Otter, S. J.
    Chatterjee, J.
    Stewart, A. J.
    Michael, A.
    CLINICAL ONCOLOGY, 2019, 31 (12) : 834 - 843
  • [29] Prediction of overall survival and response to immune checkpoint inhibitors: An immune-related signature for gastric cancer
    Wang, Zheng
    Li, Xiang
    Xu, Ying
    TRANSLATIONAL ONCOLOGY, 2021, 14 (06):
  • [30] Pulmonary Artery Intimal Sarcoma in a Patient with Lynch Syndrome: Response to an Immune Checkpoint Inhibitor
    Mounai, Yue
    Yoshida, Taichi
    Ito, Shogo
    Fukuda, Koji
    Shimazu, Kazuhiro
    Taguchi, Daiki
    Shinozaki, Hanae
    Takagi, Daichi
    Imai, Kazuhiro
    Yamamoto, Hiroshi
    Minamiya, Yoshihiro
    Nanjyo, Hiroshi
    Shibata, Hiroyuki
    CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 21 - 29